Fig. 1.

SRY-box containing gene 30 (SOX30) was downregulated in bladder cancer. Western blotting and real-time quantitative PCR (qRT-PCR) were utilized to quantify SOX30 expression levels. a Bladder cancer tissues had decreased relative SOX30 expression levels. b qRT-PCR revealed that SV-40-immortalized human uroepithelial cells and normal bladder tissues (NBT) had higher SOX30 expression levels compared to T24 and 5637 bladder cancer cell lines. Data is depicted in terms of mean ± SD.**P < 0.01. c Western blotting revealed that pair-matched adjacent normal bladder tissues had higher SOX30 expression levels compared to bladder cancer tissues. d Western blotting uncovered that SV-40-immortalized human uroepithelial cells and NBT had higher SOX30 expression levels compared to T24 and 5637 bladder cancer cell lines